Home >
Medicine Info >
Mopaday (500/15 mg) Tablet
Loading interface...

Mopaday (500/15 mg) Tablet

Manufactured byWockhardt Ltd.
ContainsMetformin (500 mg) + Pioglitazone (15 mg)
Description
Mopaday (500/15 mg) Tablet is a combination medicine used to control high blood glucose levels in patients with type 2 diabetes mellitus. Patients are advised to maintain a strict exercise and diet regimen along with this medicine to get the best possible effect.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Mopaday (500/15 mg) Tablet

  • Nausea and Vomiting
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia
  • Lactic Acidosis
  • Weakness
  • Chest discomfort
  • Headache
  • Runny Nose
  • Belching and Heartburn
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Weight gain

Uses of Mopaday (500/15 mg) Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 to 3 hours of administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Severe kidney impairment

This medicine is not recommended for use in patients with a severe impairment of kidney function due to the increased risk of serious adverse effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to pioglitazone, metformin, or any other inactive ingredients present along with these medicines.

Metabolic Acidosis

This medicine is not recommended for use in patients with metabolic acidosis since it may worsen the patient's condition.

Heart Failure

This medicine is not recommended for use in patients with a history of heart failure since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
General warnings

Kidney diseases

This medicine should be used with caution in patients with a known history of kidney disease due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Stress

Use of this medicine should be discontinued in patients exposed to stressful conditions such as a fever, trauma, surgeries, or accidents since it may not be effective in controlling blood sugar levels in these conditions. Replacement with a suitable alternative should be considered under your doctor's supervision.

Type 1 diabetes

This medicine is not recommended for use in patients suffering from Type I diabetes since it is not effective in treating such patients.

Diarrhea

This medicine may cause diarrhea when therapy is initiated. In most cases, diarrhea subsides by itself. Contact your doctor if the problem persists for longer durations. Therapy may need to be discontinued in some cases based on the clinical condition.

Cardiovascular diseases

This medicine should be used with extreme caution in patients with a known history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of heart function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Liver diseases

This medicine should be used with caution in patients with a known history of liver disease due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Edema

This medicine should be used with caution in patients with edema due to the increased risk of worsening of the patient's condition.

Ovulation

This medicine should be used with caution due to the increased chances of ovulation in premenopausal anovulatory women. Adequate contraceptive measures are recommended for such patients to avoid an unplanned pregnancy.

Fractures

This medicine may increase the risk of fractures in some patients. This risk is especially higher in female patients. Close monitoring of bone health is recommended during treatment with this medicine. Replacement with a suitable alternative may be required based on the clinical condition.

Pediatric Use

This medicine is not recommended for use in children and adolescents.

Antidiabetic agents

This medicine should be used with caution in patients taking other antidiabetic agents due to the increased risk of very low blood glucose levels. Close monitoring of blood glucose levels and appropriate dose adjustments may be required based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Amlodipine

Estradiol

Gatifloxacin

Ketoconazole

Gemfibrozil

Iodinated Contrast Media

Aloe Vera

Insulin injection

Disease interactions

Lactic Acidosis

This medicine may cause lactic acidosis in some patients. This risk is especially higher in patients with kidney diseases, heart diseases, or septicemia. Close monitoring of blood glucose levels, kidney function, heart function, and liver function may be required for such patients based on the clinical condition. Report any symptoms such as fatigue, breathing difficulty, increased sleep, nausea, vomiting, diarrhea, irregular heartbeat, etc. to the doctor immediately. Appropriate corrective measures and discontinuation of therapy may be required in some cases based on the clinical condition.

Vitamin B12 deficiency

This medicine should be used with extreme caution in patients with vitamin B12 deficiency since it may worsen the patient's condition. Appropriate vitamin B12 supplementation and dose adjustments may be required based on the clinical condition.

Congestive heart failure

This medicine is not recommended for use in patients with a known history of congestive heart failure due to the increased risk of fluid retention and worsening of the heart failure.

Bladder cancer

Use of this medicine is not recommended in patients having an active bladder tumor since it may worsen the patient's condition.

Liver Disease

This medicine should be used with extreme caution in patients with a known history of liver impairment due to the increased risk of adverse effects. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Anemia

This medicine is not recommended for use in patients suffering from anemia since it may worsen the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine as instructed by your doctor. It is advised to take this medicine with meals. Your dose is likely to change over time based on therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. You should always carry a sugar candy with you to counteract unexpected lowering of blood sugar levels. Do not change the dose or duration of use without consulting your doctor. This medicine will show better results if you maintain a strict exercise and diet regimen. Consult the doctor if you experience any undesirable side effects.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Metformin decreases absorption of glucose from the intestines and increases the action of insulin in the body. Pioglitazone decreases insulin resistance without causing any strain on the pancreas and reduces the production of glucose from the liver.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Thiazolidinediones, Oral Biguanides, Antidiabetic combinations

Schedule

Schedule H

DailyMed - Pioglitazone hydrochloride tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 16 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f2d7000-37ca-4e09-98ec-07d1c0354cb3

Pioglitazone | C19H20N2O3S - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 16 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/4829#section=Top

DailyMed - Metformin hcl tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d98aea3-35ba-447a-b88f-a5a20b612b2f

Metformin | C4H11N5 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 1 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/4091
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 15 Nov 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.